Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$361K Buy
7,567
+116
+2% +$6.37K 0.02% 898
2015
Q2
$434K Sell
7,451
-512
-6% -$27.6K 0.03% 840
2015
Q1
$402K Sell
7,963
-266
-3% -$13K 0.02% 874
2014
Q4
$370K Sell
8,229
-782
-9% -$32.8K 0.02% 879
2014
Q3
$332K Buy
9,011
+870
+11% +$34.5K 0.02% 879
2014
Q2
$359K Buy
8,141
+904
+12% +$41K 0.03% 841
2014
Q1
$314K Sell
7,237
-357
-5% -$15.9K 0.02% 867
2013
Q4
$323K Buy
7,594
+124
+2% +$4.71K 0.03% 804
2013
Q3
$254K Buy
7,470
+1,064
+17% +$34.7K 0.02% 834
2013
Q2
$200K Buy
+6,406
New +$208K 0.02% 880

Other funds holding CNMD

OFI Advisors's CNMD Position: Q3 2015 in Review

OFI Advisors increased its CONMED (CNMD) stake by 1.6% in Q3 2015, buying an estimated $6.37K and bringing the position to 7,567 shares worth $361K. The position accounts for 0.02% of the portfolio, ranked #898.

OFI Advisors first reported a position in CNMD in Q2 2013 and has held it in 10 quarters since. The position peaked at $434K in Q2 2015. 157 funds tracked by Wall St. Rank hold CNMD as of Q3 2015.

  • OFI Advisors held 7,567 shares of CONMED worth $361K as of Q3 2015.
  • OFI Advisors bought 116 CONMED shares in Q3 2015, an estimated $6.37K.
  • CONMED made up 0.02% of OFI Advisors's portfolio in Q3 2015, its #898 holding.
  • OFI Advisors first reported a position in CONMED in Q2 2013 and has held it in 10 quarters since.
  • OFI Advisors's CONMED position peaked at $434K in Q2 2015.
  • 157 funds tracked by Wall St. Rank held CONMED as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.